Time-to-answer stalls after sequencing.
Data can move quickly, but reporting, review, triage, and escalation often remain manual or unclear.
For commercial, centralized, and reference labs
Pathogen genomics, operationalized for commercial labs.
Theiagen helps labs turn pathogen sequencing capacity into validated workflows, interpretable outputs, and scalable services that customers can actually use.
Open, reproducible workflows
Validation-aware implementation
Pathogen genomics specialists
The bottleneck
Commercial labs do not need another sequencing story. They need an operating model.
The hard part is moving from isolated sequencing runs to reliable service lines that laboratory leaders, scientific directors, commercial teams, and customers can trust.
Validation expectations are real.
New assays need reproducible analysis, versioned workflows, defensible QC, and clear evidence trails.
Customers need usable intelligence.
Hospital systems, infection prevention, pharma, food, and public-sector buyers need outputs built for decisions.
Specialist teams are scarce.
Bioinformatics expertise is difficult to hire, retain, and standardize across a growing test menu.
Commercial lab operating layer
The operational layer between sequencing data and commercial lab services.
Theiagen brings pathogen-specific bioinformatics, training, workflow design, and support into a launch model that can be validated, explained, and transferred into lab operations.
Workflow architecture
Taxon-aware pipelines, QC structure, metadata requirements, run review patterns, and versioned implementation plans.
Operational enablement
Training for scientific, technical, and commercial teams so outputs are understood and used consistently.
Launch and scale support
Review workflows, troubleshooting, reporting patterns, and customer-facing launch support for new service lines.
01
Design the pathogen-genomics service line.Use case, assay scope, target customers, output structure, and operational handoffs.
02
Implement reproducible analysis.Workflow selection, parameters, QC gates, run review, versioning, and documentation.
03
Package the outputs for adoption.Technical appendix, executive summary, customer education, pilot metrics, and launch readiness.
Fixed-scope pilots
Start with a pilot that proves the operating model.
Each pilot is designed to produce usable proof artifacts: workflow map, validation considerations, sample output, operating requirements, and a launch recommendation.
C. auris transmission intelligence pilot
Evaluate how sequencing and relatedness analysis can support outbreak investigation, infection prevention, and customer-facing reporting.
- Sample-to-report workflow design
- QC and relatedness interpretation guardrails
- Customer-ready report structure
AMR / CRE cluster intelligence pilot
Turn genomic and resistance context into a structured intelligence product for infection prevention, stewardship, and lab customers.
- AMR evidence structure
- Cluster and relatedness review model
- Customer-facing decision support format
Pathogen-genomics launch package
Plan a service line from workflow and validation through reporting, training, sales enablement, and launch support.
- Service menu and workflow roadmap
- Validation and documentation plan
- Launch enablement materials
Launch support
Built for the teams that have to make pathogen genomics real.
A commercial launch needs more than a pipeline. Theiagen helps teams define what the lab will sell, how it will be validated, what customers will receive, and how internal teams will support it.
Stakeholder value
One operating model, different value for each buyer in the room.
Laboratory leaders
Launch credible pathogen-genomics services without building every workflow, report, and support process from scratch.
Scientific directors
Use reproducible, explainable workflows with clearer evidence trails and review expectations.
Commercial teams
Bring a concrete service story to customers with example outputs, implementation scope, and practical use cases.
Customers
Receive pathogen-genomics outputs that are structured for infection prevention, surveillance, stewardship, or operational decisions.
Pathogen-genomics expertise
Public-health rigor, adapted for commercial lab execution.
Theiagen's public work spans multi-laboratory implementations, international bioinformatics enablement, and practical training programs in public health genomics. The commercial lab offer brings that workflow, training, and support discipline into focused service-line launches.
Multi-labimplementation experience from public health genomics programs
Internationalbioinformatics enablement and workflow support context
Trainingprograms that help teams operate workflows with confidence
Terra and Dockstore ecosystem familiarity
TheiaCoV, Theiagen TheiaProk™, Theiagen TheiaEuk™, TheiaMeta, TheiaViral
Workflow implementation, training, and support
Evidence-first reporting mindset
Pilot process
A focused path from opportunity to launch decision.
1
Use-case selection
Pick the commercial opportunity, target customer, and operational constraints.
2
Workflow design
Map inputs, metadata, pipelines, QC gates, review, and output requirements.
3
Sample analysis
Run representative analysis or workflow evaluation within the pilot scope.
4
Output package
Produce a sample report structure, technical appendix, and workflow evidence map.
5
Launch decision
Review feasibility, validation path, staffing, customer fit, and next-step roadmap.
Sample output package
Show customers the value, not just the data.
The pilot produces tangible outputs your team can review, refine, and use in customer conversations as the service moves toward launch.
Decision-ready summary
Plain-language finding categories, action context, uncertainty notes, and recommended escalation patterns.
Evidence trail
QC, pipeline versioning, metadata, analytical notes, and review checkpoints for scientific teams.
Operational roadmap
Handoffs, staffing expectations, review model, validation considerations, and launch-readiness gaps.
Resources
Resources for your launch team.
Commercial lab pathogen-genomics guide
A practical view of where pathogen genomics can create defensible commercial services.
Open resourceOne-page pilot overview
A concise overview for leadership, business development, and scientific stakeholders.
Open resourceValidation planning checklist
Key questions for workflow versioning, QC, review, metadata, and documentation.
Open resourceLaunch-readiness worksheet
A practical frame for evaluating customer fit, operating requirements, and next steps.
Open resourceFAQ
Questions commercial lab teams usually ask first.
Is this a sequencing platform or reagent offering?
No. Theiagen is focused on bioinformatics, workflow implementation, reporting structure, validation support, training, and operational launch support.
Can this fit an existing sequencing workflow?
Yes. The pilot begins by mapping current instrumentation, sample types, metadata, operational constraints, and reporting needs before recommending the implementation path.
Can we start without committing to a full service launch?
Yes. The fixed-scope pilot is designed to help leadership evaluate feasibility, customer value, validation scope, and operating requirements before broader rollout.
What kinds of customers can benefit?
Potential users include hospital systems, infection prevention teams, public health partners, pharma or biotech teams, food safety organizations, and other customers that need pathogen-genomics intelligence.
How are claims handled?
Theiagen avoids unsupported claims. Pilot outputs are structured around reproducible workflows, evidence trails, clear limitations, and the lab's validation and review framework.
What is the best first step?
Pick one commercial use case, one pilot question, and the internal stakeholders who need to approve a launch decision. Theiagen can help shape the scope from there.
Start the conversation
Build a pathogen-genomics service line your customers can understand and your lab can operate.
Tell us which pathogen-genomics service you want to bring to market first. We will help shape a pilot with clear outputs, review points, and launch-ready next steps.
Good fit signals
Your team is evaluating a pathogen-genomics service line, needs validation-aware implementation support, or wants customer-ready output examples for a commercial pilot.